Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin
Ronen Sadeh, Israa Sharkia, Gavriel Fialkoff, et al.
Nature Biotechnology (2021) Vol. 39, Iss. 5, pp. 586-598
Open Access | Times Cited: 109

Showing 51-75 of 109 citing articles:

Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies
Christoffer Trier Maansson, Louise Skov Thomsen, Peter Meldgaard, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1243-1243
Open Access | Times Cited: 2
Targeting therapy-persistent residual disease
Xiaoxiao Sun, Lani F. Wu, Steven J. Altschuler, et al.
Nature Cancer (2024)
Closed Access | Times Cited: 2
Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer
Adriaan Vanderstichele, Pieter Busschaert, C. Landolfo, et al.
npj Genomic Medicine (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 14
Androgen receptor genomic alterations and treatment resistance in metastatic prostate cancer
Edmond M. Kwan, Alexander W. Wyatt
The Prostate (2022) Vol. 82, Iss. S1
Open Access | Times Cited: 14
Machine learning guided signal enrichment for ultrasensitive plasma tumor burden monitoring
Adam J. Widman, Minita Shah, Nadia Øgaard, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 13
Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease
Harini Lakshminarayanan, Dorothea Rutishauser, Peter Schraml, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 20
Profiling of cell‐free DNA methylation and histone signatures in pediatric NAFLD: A pilot study
Diana Búzová, Maria Rita Braghini, Salvatore Daniele Bianco, et al.
Hepatology Communications (2022) Vol. 6, Iss. 12, pp. 3311-3323
Open Access | Times Cited: 12
Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer
Stefania Morganti, Heather A. Parsons, Nancy U. Lin, et al.
npj Breast Cancer (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Cell-free DNA reveals distinct pathology of multisystem inflammatory syndrome in children
T. Andargie, Katerina Roznik, Neelam Redekar, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 21
Open Access | Times Cited: 6
The rising tide of cell-free DNA profiling: from snapshot to temporal genome analysis
Abel J. Bronkhorst, Vida Ungerer, Angela Oberhofer, et al.
Journal of Laboratory Medicine (2022) Vol. 46, Iss. 4, pp. 207-224
Open Access | Times Cited: 10
Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma
Sally Temraz, Rihab Nasr, Deborah Mukherji, et al.
Expert Review of Molecular Diagnostics (2022) Vol. 22, Iss. 5, pp. 507-518
Closed Access | Times Cited: 10
Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets
Huiwen Che, Tatjana Jatsenko, Liesbeth Lenaerts, et al.
Clinical Chemistry (2022) Vol. 68, Iss. 9, pp. 1164-1176
Open Access | Times Cited: 10
Profiling disease and tissue-specific epigenetic signatures in cell-free DNA
Angela Oberhofer, Abel J. Bronkhorst, Vida Ungerer, et al.
Journal of Laboratory Medicine (2022) Vol. 46, Iss. 4, pp. 283-294
Open Access | Times Cited: 10
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells
Johan Vad‐Nielsen, Nicklas Heine Staunstrup, Magnus Lindkvist Kjeldsen, et al.
Translational Lung Cancer Research (2023) Vol. 12, Iss. 1, pp. 42-65
Open Access | Times Cited: 5
Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery
Lucas Penny, Sasha Main, Steven De Michino, et al.
Biochemistry and Cell Biology (2024) Vol. 102, Iss. 4, pp. 291-298
Open Access | Times Cited: 1
Clinical use of circulating tumor DNA analysis in patients with lymphoma
Bettina Bisig, Karine Lefort, Sylvain Carras, et al.
Human Pathology (2024), pp. 105679-105679
Open Access | Times Cited: 1
Leveraging sequences missing from the human genome to diagnose cancer
Ilias Georgakopoulos-Soares, Ofer Yizhar Barnea, Ioannis Mouratidis, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 13
It’s all in the combination: decoding the epigenome for cancer research and diagnostics
Noa Furth, Efrat Shema
Current Opinion in Genetics & Development (2022) Vol. 73, pp. 101899-101899
Open Access | Times Cited: 9
Liquid Biopsies to Evaluate Immunogenicity of Gynecological/Breast Tumors: On the Way to Blood-Based Biomarkers for Immunotherapies
Corinna Keup, Rainer Kimmig, Sabine Kasimir‐Bauer
Breast Care (2020) Vol. 15, Iss. 5, pp. 470-480
Open Access | Times Cited: 13
Cell Types of Origin in the Cell Free Transcriptome in Human Health and Disease
Sevahn K. Vorperian, Mira N. Moufarrej, Stephen R. Quake
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 11
B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodies
Ilana Fox-Fisher, Sheina Piyanzin, Mayan Briller, et al.
Med (2022) Vol. 3, Iss. 7, pp. 468-480.e5
Open Access | Times Cited: 8
Epigenetic markers and therapeutic targets for metastasis
Carolyn J. Kravitz, Qin Yan, Don X. Nguyen
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 2, pp. 427-443
Open Access | Times Cited: 4
Circulating nucleic acids as liquid biopsies for disease prediction, screening and diagnosis
Yuqing Sun, Yongling Tang, Long Yu, et al.
Science China Chemistry (2023) Vol. 66, Iss. 11, pp. 3006-3023
Closed Access | Times Cited: 4
Exhaustive identification of genome-wide binding events of transcriptional regulators with ICEBERG
Anna Nordin, Pierfrancesco Pagella, Gianluca Zambanini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Liquid biopsies to predict CDK4/6 inhibitor efficacy and resistance in breast cancer
Sasha Main, David W. Cescon, Scott V. Bratman
Cancer Drug Resistance (2022) Vol. 5, Iss. 3, pp. 727-48
Open Access | Times Cited: 6

Scroll to top